Find all needed information about Corcap Cardiac Support. Below you can see links where you can find everything you want to know about Corcap Cardiac Support.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790142/
The CorCap Cardiac Support Device (Acorn Cardiovascular, Inc.) is the first device that specifically addresses ventricular remodeling in heart failure by reducing wall stress. We previously reported outcomes from the Acorn randomized trial to a common closing date (22.9 months of follow up).Cited by: 86
https://www.annalsthoracicsurgery.org/article/S0003-4975(07)00892-2/fulltext
The CorCap Cardiac Support Device (CSD; Acorn Cardiovascular Inc, St. Paul, MN) is a fabric mesh device that is surgically implanted around the heart. It is designed to provide circumferential diastolic support and reduce LV wall stress.Cited by: 175
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527692/
Background. Ventricular remodeling deteriorates myocardial function in congestive heart failure patients. Ventricular restraint therapy using Cardiac Support Device (CSD) is designed to reduce the amount of stress inside the dilated ventricles which in turn halts remodeling.Cited by: 3
https://www.healio.com/cardiology/hf-transplantation/news/print/cardiology-today/%7Bb317e6f9-5ccd-4d61-af29-60fe56a51b27%7D/acorn-cardiac-restraint-device-improved-heart-failure-outcomes
ACORN tested the CorCap Cardiac Support Device (Acorn Cardiovascular Inc.), which resembles a net that is placed around and attached to the heart to …
https://clinicaltrials.gov/ct2/show/NCT00630266
Mar 06, 2008 · The Acorn CorCap Cardiac Support Device (CSD) is a new therapy for the treatment of heart failure that is designed to reduce left ventricular dilation, which is one of the most important pathophysiological mechanisms underlying the clinical syndrome of heart failure.
https://www.sciencedirect.com/science/article/pii/S0022522311006337
Background. The CorCap cardiac support device (Acorn Cardiovascular, Inc, St Paul, Minn) is the first device that specifically addresses ventricular remodeling in …Cited by: 86
https://www.citizen.org/article/letter-opposing-potential-approval-of-corcap-cardiac-support-device/
Nov 12, 2008 · Public Citizen’s Health Research Group writes to you today to express our deep concern about the Food and Drug Administration’s (FDA’s) ongoing review and possible approval of the CorCap (Acorn Cardiovascular) cardiac support device.
https://www.annalsthoracicsurgery.org/article/S0003-4975(07)00892-2/abstract
The CorCap Cardiac Support Device (CSD; Acorn Cardiovascular, Inc, St. Paul, MN) is an implantable device that attenuates LV remodeling. Methods. The Acorn trial assessed the safety and efficacy of the CSD in 300 heart failure patients. Patients needing mitral surgery (n = 193) were randomized to mitral surgery alone or mitral surgery plus CSD.Cited by: 175
https://www.jtcvs.org/article/S0022-5223(11)00633-7/fulltext
Jul 15, 2011 · The CorCap cardiac support device (Acorn Cardiovascular, Inc, St Paul, Minn) is the first device that specifically addresses ventricular remodeling in heart failure by reducing wall stress. We previously reported outcomes from the Acorn randomized trial to a common closing date (22.9 months of follow-up). This report summarizes results of extended followup to 5 years.Cited by: 86
https://www.sciencedirect.com/science/article/pii/S0003497512016487
Material Properties of CorCap Passive Cardiac Support Device. ... (HF). Ventricular restraint therapy using a cardiac support device (CSD) is designed to reduce the amount of stress inside the dilated ventricles, which in turn halts remodeling. ... R.G. WalshDesign and features of the Acorn CorCap Cardiac Support Device: the concept of passive ...Cited by: 3
Need to find Corcap Cardiac Support information?
To find needed information please read the text beloow. If you need to know more you can click on the links to visit sites with more detailed data.
